메뉴 건너뛰기




Volumn 48, Issue 12, 2003, Pages 3542-3543

Successful Tumor Necrosis Factor α Blockade Treatment in Therapy-Resistant Sarcoidosis

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

EID: 0346850596     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11357     Document Type: Article
Times cited : (75)

References (5)
  • 2
    • 0035118698 scopus 로고    scopus 로고
    • Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
    • Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, et al. Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001;69:1847-55.
    • (2001) Infect Immun , vol.69 , pp. 1847-1855
    • Mohan, V.P.1    Scanga, C.A.2    Yu, K.3    Scott, H.M.4    Tanaka, K.E.5    Tsang, E.6
  • 3
    • 0035800027 scopus 로고    scopus 로고
    • Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
    • Yee AMF, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy. Ann Intern Med 2001;135:27-31.
    • (2001) Ann Intern Med , vol.135 , pp. 27-31
    • Yee, A.M.F.1    Pochapin, M.B.2
  • 4
    • 0028143211 scopus 로고
    • Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
    • Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
    • (1994) Lancet , vol.344 , pp. 1105-1110
    • Elliott, M.J.1    Maini, R.N.2    Feldmann, M.3    Kalden, J.R.4    Antoni, C.5    Smolen, J.S.6
  • 5
    • 0031660364 scopus 로고    scopus 로고
    • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
    • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
    • (1998) Arthritis Rheum , vol.41 , pp. 1552-1563
    • Maini, R.N.1    Breedveld, F.C.2    Kalden, J.R.3    Smolen, J.S.4    Davis, D.5    Macfarlane, J.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.